Journal article Open Access

EFFICACY AND SAFETY OF VITAMIN-C FOR IRON ANEMIA PATIENTS

Dr Fatima Khanum, Dr Aneeqa Zia, Dr Usman Saleem

Introduction: Despite the increasing use of targeted therapies in cancer patients, chemotherapy remains a mainstay of cancer treatment.

Objectives: The main objective of the study is to analyse the efficacy and safety of Vitamin-C for iron anemia patients. Material and methods: This cross sectional study was conducted in Health department Punjab during 2019 to 2020. The data was collected from those patients who were suffering from iron deficiency anemia. Patients were treated for 3 months and assessed with a complete blood count every 2 weeks for 2 months; iron metabolism was measured at week 8.

Results: The data was collected from 100 female patients. The only factors which emerged as statistically significant from the adjusted logistic regression analysis model were insufficient intakes of iron (OR = 7.39; 95% CI: 1.45-37.57) and vitamin C (OR = 6.14; 95% CI: 1.34-28.27), frequent (≥2 times per week) tea consumption (OR = 0.01; 95% CI: 0.01-0.08), infrequent (≤2 times per week) red meat consumption (OR = 3.71; 95% CI: 1.01-13.61), and the possession of a personal history of IDA (OR = 6.00; 95% CI: 1.45-24.76).

Conclusion: It is concluded that taking oral iron alone was equivalent to taking oral iron supplemented with vitamin C in improving hemoglobin level and iron stores. Our results suggest that vitamin C is not essential for patients with IDA.

Files (699.1 kB)
Name Size
237.paper 523.pdf
md5:dbfa066bd01355cc0cdadaf5aa5749ed
699.1 kB Download
15
10
views
downloads
All versions This version
Views 1515
Downloads 1010
Data volume 7.0 MB7.0 MB
Unique views 1212
Unique downloads 77

Share

Cite as